Skip to main content

Table 3 Results of 12 months aspiration therapy on quality of life, blood and urine values and HbA1c level (the latter for diabetic subjects only)

From: Aspiration therapy for obesity; a safe and effective treatment

Quality of life and biochemical data Baseline
n = 20
12 months
n = 20
p
Quality of life
 Visual Analogue Scale* 63 (15) 83 (14) <0.01
 EuroQoL-5D* 0.73 (0.25) 0.88 (0.13) <0.01
Blood samples
 Potassium (mmol/l) 4.4 (4.2–4.5) 4.3 (4.0–4.5) 0.57
 Sodium (mmol/l) 140 (139–141.5) 141.5 (140–142) 0.02
 Creatinine (umol/l) 62.5 (53–67) 68 (58.5–73.5) <0.01
Urine samples
 24 h potassium (mmol) 66 (54–87) 57 (40.5–76.5) 0.10
 24 h sodium (mmol) 203 (122–267) 147.5 (110.5–188.5) 0.02
 24 h chloride (mmol) 188 (141.5–246.5) 106 (70–143) <0.01
 Osmolality (mmol/kg) 482 (377–681) 394 (335–571) 0.30
 pH 6.0 (5.5–6.7) 6.7 (6.2–7.0) 0.02
Subjects with diabetes mellitus Baseline
n = 7
12 months
n = 7
p
 Blood samples
  HbA1c (mmol/mol) 47 (43–66) 42 (36–64) 0.03
  1. The five subjects who aborted treatment are excluded (presentation as per protocol at 1 year). Data are presented as median (IQR) or mean (SD), the latter indicated by *